JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
84 hedge funds and large institutions have $81.8M invested in Jounce Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
53% less capital invested
Capital invested by funds: $176M → $81.8M (-$93.9M)
Holders
84
Holding in Top 10
2
Calls
$18K
Puts
–
Top Buyers
| 1 | +$607K | |
| 2 | +$443K | |
| 3 | +$320K | |
| 4 |
Two Sigma Investments
New York
|
+$273K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$267K |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$2.44M | |
| 3 | -$1.42M | |
| 4 |
Man Group
London,
United Kingdom
|
-$1.3M |
| 5 |
BlackRock
New York
|
-$1.3M |